Novartis revenue decreased from $51.9 billion in 2018 to $47.4 billion in 2019, a (8.6%) decrease.
Annual Revenue ($)
Novartis revenue was $47.45 b in FY, 2019 which is a (8.6%) year over year decrease from the previous period.
Quarterly Revenue ($)
Annual Growth Rate (%)
Revenue Breakdown
Business Segment
Geographic Segment
Novartis revenue breakdown by business segment: 20.5% from Sandoz and 79.5% from Innovative Medicines
Novartis revenue breakdown by geographic segment: 5.6% from Japan , 34.3% from United States, 5.1% from France, 8.7% from Germany and 46.3% from Other
| FY, 2018 | FY, 2019 | FY, 2017 | |
|---|---|---|---|
| Innovative Medicines | $35.63 b | $37.71 b | $33.03 b |
| Sandoz | $10.04 b | $9.73 b | $10.06 b |
| Alcon | $7.15 b | $6.02 b |
| FY, 2018 | FY, 2019 | FY, 2017 | |
|---|---|---|---|
| United States | $17.56 b | $16.28 b | $16.94 b |
| Germany | $4.18 b | $4.12 b | $3.69 b |
| United Kingdom | $1.26 b | $1.16 b | |
| France | $2.71 b | $2.44 b | $2.49 b |
| Other | $22.17 b | $21.1 b | $20.82 b |
| Switzerland | $852 m | $848 m | $836 m |
| Japan | $3.17 b | $2.66 b | $3.18 b |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.